Pharmacological treatment for osteoporosis

• Autor(a) principal: Mata,Priscila Rosendo da
• Data de Publicação: 2012
• Outros Autores: Martins,Paulo Andrade, Brito,Leonardo da Gama, Ramos,Monique Meyer Pitta, Junior,Manoelito Coelho dos Santos
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Geriatrics, Gerontology and Aging (Online)
• Texto Completo: https://ggaging.com/details/184
• topic: Bone,therapy, prevent ion, control, osteoporosis.

<p>The increase of life expectancy has led several concerns about people's quality of life, especially in the health area. In this context, there is an increase in the incidence of chronic degenerative diseases, as such as osteoporosis. This research aims to conduct a theoretical study about the pharmacological and non-pharmacological therapies available for the preventation and treatment of this disease. This study becomes important as it intends to show the main pharmacological and non-pharmacological drugs used in the treatment and mainly in the prevention of this disease, so prevalent nowadays. The methodology used for this study was a literature review and it aimed to compile the main available information about the theme of the study. Osteoporosis is a bone metabolic disease, characterized by a decrease in bone mass and deterioration of the microarchitecture of bone tissue, resulting in a raise of fracture susceptibility, and it is mainly related to age, affecting men and women. The therapeutic agents used in the treatment of osteoporosis can be divided into two classes: compounds with an anti-reabsorptive action (bisphosphonates, calcitonin, estrogens and selective estrogen receptor modulators) and bone-forming agents (fluoride, parathyroid hormone, teriparatide). Some newer drugs, as strontium ranelate, are also available for the use in the treatment of this disease.</p>